Exane Derivatives’s Airbnb ABNB Stock Holding History

Exane Derivatives’s Portfolio ABNB Stock Details ABNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,903	Closed	-$670K	–	762
2022 Q1	$670K	Sell	3,903 -528	-12%	-$84.1K	0.19%	141
2021 Q4	$738K	Sell	4,431 -711	-14%	-$125K	0.18%	126
2021 Q3	$863K	Sell	5,142 -299	-5%	-$45.7K	0.21%	103
2021 Q2	$780K	Buy	+5,441	New	+$854K	0.18%	110

Other funds holding ABNB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Exane Derivatives's ABNB Position: Q2 2022 in Review

Exane Derivatives sold out of Airbnb (ABNB) in Q2 2022, closing a stake of 3,903 shares — an estimated $670K sold.

Exane Derivatives first reported a position in ABNB in Q2 2021 and held it in 4 quarters. The position peaked at $863K in Q3 2021. 972 funds tracked by Wall St. Rank hold ABNB as of Q2 2022.

Exane Derivatives reported no remaining Airbnb position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 3,903 Airbnb shares in Q2 2022, an estimated $670K.
Exane Derivatives first reported a position in Airbnb in Q2 2021 and held it in 4 quarters.
Exane Derivatives's Airbnb position peaked at $863K in Q3 2021.
972 funds tracked by Wall St. Rank held Airbnb as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.